EP 4314039 A1 20240207 - EFFICIENT TCR GENE EDITING IN T LYMPHOCYTES
Title (en)
EFFICIENT TCR GENE EDITING IN T LYMPHOCYTES
Title (de)
EFFIZIENTE TCR-GENEDITIERUNG IN T-LYMPHOZYTEN
Title (fr)
ÉDITION DE GÈNE DU TCR EFFICACE DANS DES LYMPHOCYTES T
Publication
Application
Priority
- US 202163165509 P 20210324
- US 2022021820 W 20220324
Abstract (en)
[origin: TW202309272A] The present disclosure relates to engineered T cells and methods of making and using the same, as well as reagents for making the engineered T cells.
IPC 8 full level
C07K 14/725 (2006.01); C12N 5/0783 (2010.01); C12N 9/22 (2006.01); C12N 15/113 (2010.01); C12N 15/90 (2006.01)
CPC (source: EP KR)
A61K 39/4611 (2023.05 - KR); A61K 39/4632 (2023.05 - KR); C07K 14/7051 (2013.01 - EP KR); C12N 5/0636 (2013.01 - EP KR); C12N 9/22 (2013.01 - EP KR); C12N 15/1138 (2013.01 - KR); C12N 15/625 (2013.01 - KR); C12N 15/907 (2013.01 - EP KR); C07K 2319/09 (2013.01 - KR); C07K 2319/50 (2013.01 - EP KR); C12N 15/1138 (2013.01 - EP); C12N 2310/20 (2017.05 - EP KR); C12N 2501/2302 (2013.01 - KR); C12N 2501/2307 (2013.01 - KR); C12N 2501/2315 (2013.01 - KR); C12N 2510/00 (2013.01 - EP KR); C12N 2800/80 (2013.01 - KR)
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
Designated validation state (EPC)
KH MA MD TN
DOCDB simple family (publication)
AR 125225 A1 20230628; CN 117062831 A 20231114; EP 4314039 A1 20240207; TW 202309272 A 20230301
DOCDB simple family (application)
AR P220100726 A 20220325; CN 202280023611 A 20220324; EP 22716698 A 20220324; TW 111111213 A 20220324